Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, remains a significant health concern worldwide, particularly in developing countries. Despite advances in healthcare, effective management of enteric fever in clinical practice remains challenging. This article aims to explore the most effective strategies for managing this condition.
Rapid and accurate diagnosis is the cornerstone of effective management. Blood culture remains the gold standard for diagnosis, but its sensitivity can be limited. Newer diagnostic techniques, such as PCR and serological tests, offer promising alternatives.
Antibiotic therapy is the mainstay of treatment for enteric fever. However, the increasing prevalence of multidrug-resistant strains requires careful antibiotic selection. Fluoroquinolones, third-generation cephalosporins, and azithromycin are currently the drugs of choice.
Vaccination is a crucial preventive measure. Two vaccines - the oral live attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine - are currently available. However, their efficacy varies, and they are not suitable for all populations. Continued research into more effective vaccines is needed.
Public health measures, such as improved sanitation and safe drinking water, play a significant role in preventing enteric fever. These measures are particularly important in endemic areas where antibiotic resistance is high.
Effective management of enteric fever requires a multifaceted approach, including accurate diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Clinicians must stay abreast of the latest developments in diagnosis and treatment, while public health initiatives must focus on prevention. As antibiotic resistance continues to rise, the need for new treatment strategies and vaccines becomes increasingly urgent.
1.
The White House has postponed its plan to outlaw menthol cigarettes indefinitely.
2.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
3.
Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.
4.
Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.
5.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
1.
Understanding the Importance of Knowing Your MCV Normal Range
2.
Modern Concepts in Oncology Across Clinical Settings
3.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
4.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
5.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation